HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 56 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q2 2020 | $9,000 | +200.0% | 11,891 | +0.3% | 0.00% | – |
| Q1 2020 | $3,000 | -57.1% | 11,858 | +10.7% | 0.00% | – |
| Q4 2019 | $7,000 | 0.0% | 10,709 | -0.2% | 0.00% | – |
| Q3 2019 | $7,000 | -58.8% | 10,729 | +2.2% | 0.00% | – |
| Q2 2019 | $17,000 | -34.6% | 10,500 | 0.0% | 0.00% | – |
| Q1 2019 | $26,000 | +333.3% | 10,500 | +320.0% | 0.00% | – |
| Q4 2018 | $6,000 | – | 2,500 | +4066.7% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 60 | -99.6% | 0.00% | – |
| Q2 2018 | $44,000 | +214.3% | 13,539 | +238.5% | 0.00% | – |
| Q1 2018 | $14,000 | – | 4,000 | +57042.9% | 0.00% | – |
| Q4 2017 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,675,889 | $6,797,000 | 5.97% |
| PERKINS CAPITAL MANAGEMENT INC | 449,950 | $1,143,000 | 0.89% |
| Diametric Capital, LP | 116,754 | $297,000 | 0.23% |
| Granahan Investment Management | 924,300 | $2,348,000 | 0.17% |
| Requisite Energy Fund I LP | 100,000 | $254,000 | 0.10% |
| Requisite Capital Management, LLC | 100,000 | $254,000 | 0.10% |
| B. Riley Wealth Advisors, Inc. | 250,000 | $635,000 | 0.09% |
| Kalos Management, Inc. | 74,420 | $179,000 | 0.09% |
| Crow Point Partners, LLC | 65,475 | $164,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 35,000 | $89,000 | 0.02% |